Posterior hippocampal volumes are associated with remission rates in patients with major depressive disorder

Biological Psychiatry
Glenda MacqueenRussell Joffe

Abstract

The hippocampus (HC) is smaller in patients with recurrent major depressive disorder (MDD), but few longitudinal studies have examined whether volume is associated with clinically meaningful outcomes such as response to treatment. We compared regional (head and body/tail) HC volumes in 46 patients with MDD, 14 of whom remitted after 8 weeks of first treatment to HC volumes of 32 patients who were not in remission after 8 weeks. Patients who remitted had larger pretreatment hippocampal body/tail volumes bilaterally compared with those who were not in remission at 8 weeks. This difference was not apparent in either the right or left hippocampal head. These findings extend a small number of previous reports, suggesting that regional brain volumes might be associated with rate and extent of clinical response to antidepressant medication.

References

Jun 23, 2000·Biological Psychiatry·K VakiliD A Yurgelun-Todd
Dec 26, 2001·Annual Review of Psychology·Richard J DavidsonKatherine Putnam
Jul 2, 2002·The American Journal of Psychiatry·Thomas FrodlHans-Jürgen Möller
Jul 12, 2002·International Journal of Geriatric Psychiatry·Ming-Hong HsiehDavid C Steffens
Jul 2, 2003·Brain Research·Sâmia Regiane Lourenço JocaFrancisco Silveira Guimarães
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON
Apr 2, 2004·The American Journal of Psychiatry·Stephanie CampbellGlenda M MacQueen
Oct 30, 2004·The American Journal of Psychiatry·Poul Videbech, Barbara Ravnkilde
Apr 12, 2005·Biological Psychiatry·Alexander NeumeisterWayne C Drevets
Jun 18, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Minke E JongsmaJohan A den Boer
Apr 5, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Kaan YucelGlenda M MacQueen
Jul 3, 2007·Hippocampus·Jerome J MallerPaul B Fitzgerald
Aug 30, 2007·Nature Neuroscience·Amar Sahay, Rene Hen
Aug 31, 2007·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Lucinéia Dos SantosHélio Zangrossi Junior
Jun 3, 2008·The British Journal of Psychiatry : the Journal of Mental Science·Klaus-Thomas KronmüllerJohannes Schröder

❮ Previous
Next ❯

Citations

Oct 22, 2010·Current Psychiatry Reports·Andrew F LeuchterBarry D Lebowitz
Oct 12, 2012·Current Psychiatry Reports·Mayur PandyaAmit Anand
Feb 12, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Thomas FrodlEva M Meisenzahl
Jul 25, 2012·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Ronald S Duman, Nanxin Li
Aug 25, 2010·Journal of Psychiatry & Neuroscience : JPN·Nikolai V MalykhinNicholas J Coupland
Aug 25, 2010·Journal of Psychiatry & Neuroscience : JPN·Glenda M Macqueen
Dec 10, 2013·Acta Neuropathologica·Paul J LucassenBoldizsár Czéh
Dec 3, 2014·Trends in Pharmacological Sciences·Olivia F O'Leary, John F Cryan
Nov 1, 2011·Expert Opinion on Medical Diagnostics·Naama Barnea-Goraly, Antonio Hardan
Feb 3, 2016·Journal of the International Neuropsychological Society : JINS·Michelle T KasselScott A Langenecker
Sep 30, 2014·Neuroscience and Biobehavioral Reviews·Syed Mohammed Qasim HussainiMi-Hyeon Jang
Jan 16, 2016·Research in Developmental Disabilities·Vicki BitsikaLinda L Agnew
Mar 12, 2013·Psychiatry Research·Claus M GrossJens M Langosch
Jun 16, 2012·Psychiatry Research·Anna SchuhmacherAstrid Zobel
Jun 29, 2012·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Chadi G AbdallahSanjay J Mathew
Feb 22, 2012·Psychiatry Research·Maura L FureyCarlos A Zarate
Aug 23, 2011·Brain and Cognition·Tracy VaillancourtHarriet Macmillan
Jun 7, 2011·Pharmacology & Therapeutics·Francesca CalabreseMarco A Riva
Sep 8, 2010·Psychiatry Research·Francesco NifosìGiulia Ida Perini
Apr 15, 2010·Brain Research Reviews·Jerome J MallerPaul B Fitzgerald
Feb 4, 2010·Journal of Psychiatric Research·Thomas FrodlEva M Meisenzahl
Nov 26, 2015·Journal of Affective Disorders·Natalia JaworskaGlenda MacQueen
Jan 3, 2009·Neuroscience Research·Naoko Kaneko, Kazunobu Sawamoto
Oct 10, 2015·Journal of Affective Disorders·Stella W Y ChanMaria J Portella
May 3, 2015·Neuroscience·N V Malykhin, N J Coupland
Apr 10, 2015·Annals of the New York Academy of Sciences·Marc S Lener, Dan V Iosifescu
Aug 4, 2015·Journal of Affective Disorders·Kee F ChiStuart M Grieve
Aug 6, 2014·European Journal of Pharmacology·Olivia F O'LearyJohn F Cryan
Jan 1, 2014·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Warren D TaylorDavid C Steffens
Apr 21, 2012·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Angela CarballedoThomas Frodl
May 20, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Chadi G AbdallahDikoma C Shungu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved